In section Market Quotes

PharmaLogic to Buy Lantheus CDMO Business and New Jersey Plant

PharmaLogic Holdings has agreed to acquire Lantheus Holdings’ contract development and manufacturing organization business and its manufacturing facility in Springfield, New Jersey, adding the site’s team to its therapeutic CDMO franchise, Agilera.

By Money Talk·November 10, 2026·2 min read·341 reads

PharmaLogic to Buy Lantheus CDMO Business and New Jersey Plant

The deal also includes a long-term agreement for Agilera to supply lutetium Lu 177 dotatate to Lantheus, PharmaLogic said Monday. Financial terms were not disclosed.

PharmaLogic, a radiopharmaceutical CDMO company, said the acquisition will make it the first therapeutic CDMO to offer a transatlantic platform. Chief Executive Officer Etienne Montagut said it would strengthen Agilera’s capabilities in radioligand therapies and expand its U.S. capacity.

PharmaLogic to Buy Lantheus CDMO Business and New Jersey Plant

Comments (0)